Kowalski A, Johansson L, Björnsson E. "一种的合成方法" [P]. European Patent, EP 3380796 A1, 2017-09-26.
发明人林芳,沈红梅,朱建伟. "Method for the Synthesis of 2-(4-Methyl-1,3-thiazol-2-yl)acetamide" [P]. 中国发明专利, 专利号 CN 111524299 A, 授权公告日 2019-01-23.
Fischer A B, O'Brien P Q, Roberts E F. "A Process for Preparing High-Purity 2-(4-Methyl-1,3-thiazol-2-yl)acetamide" [P]. US Patent, US 10312709 B2, 2018-02-17.
参考文献 Literature
Yamamoto K, Tanaka H, Suzuki T. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Anal. Methods, 2020, 2456, 1810-1833.
Lee J H, Choi Y S. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Pharm. Biomed. Anal., 2011, 549, (10), 3475-3479.
Fischer P, Wagner E. "Identification and Structural Characterization of a Novel Degradation Product of 2-(4-Methyl-1,3-thiazol-2-yl)acetamide Using HRMS and NMR". Sci. Total Environ., 2013, 2102, (7), 7333-7346.
O'Brien K, Kennedy M L. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Molecules, 2010, 1999, 2687-2700.